Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eksp Klin Farmakol ; 78(8): 3-6, 2015.
Artigo em Russo | MEDLINE | ID: mdl-26591573

RESUMO

Experiments on rats showed that 6- and 12-day course treatment by mexidol or 2-ethyl-6-methyl-3-hydroxypyridine hemisuccinate (at doses 200 mg/kg, i.p.) prevented the lipofuscin level increase in rat brain tissue, caused by occlusion of the left middle cerebral artery, both in the damaged and intact (right) cerebral hemispheres. Mexidol significantly decreased the concentration of lipofuscine after 12-days treatment, whereas 2-ethyl-6-methyl-3-hydroxypiridine hemisuccinate markedly decreased lipofuscine levels already after 6-day treatment.


Assuntos
Antioxidantes/farmacologia , Isquemia Encefálica , Encéfalo/metabolismo , Lipofuscina/metabolismo , Picolinas/farmacologia , Piridinas/farmacologia , Animais , Encéfalo/patologia , Química Encefálica/efeitos dos fármacos , Isquemia Encefálica/tratamento farmacológico , Isquemia Encefálica/metabolismo , Isquemia Encefálica/patologia , Masculino , Ratos
2.
Eksp Klin Farmakol ; 78(6): 7-11, 2015.
Artigo em Russo | MEDLINE | ID: mdl-26292507

RESUMO

We have studied the effect of a GABA conjugate with arachidonic acid (AA) on the morphological state of rat brain tissues after left median cerebral artery occlusion. The results showed that a 6- and 12-day course administration of the GABA - AA conjugate at dose of 2 mg/kg (i.p.) in rats with this model of local permanent brain ischemia led to significant recovery processes in brain tissues. The tissue morphology pattern in the group of animals treated with the GABSA - AA conjugate for 12 days was almost identical to that in intact tissues.


Assuntos
Ácidos Araquidônicos/farmacologia , Isquemia Encefálica , Fármacos Neuroprotetores/farmacologia , Ácido gama-Aminobutírico/farmacologia , Animais , Isquemia Encefálica/tratamento farmacológico , Isquemia Encefálica/patologia , Modelos Animais de Doenças , GABAérgicos/farmacologia , Masculino , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...